Neurodegeneration and peroxidases

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) are distinct neurodegenerative diseases.
• Literature suggests overlapping biochemical mechanisms in the neurodegeneration processes of AD, PD, and ALS.
• Understanding these commonalities is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To critically examine the similarities in neurodegeneration across AD, PD, and ALS.
• To propose a novel explanation for neurodegeneration based on shared biochemical pathways.
• To identify potential therapeutic targets by investigating the role of specific enzymes.

Main Methods:

• Literature review to identify commonalities in neurodegenerative processes.
• Analysis of data from own and other laboratories.
• Hypothesizing enzyme-catalyzed oxidative and apoptotic pathways in affected neurons.

Main Results:

• Identified approximately 20 commonalities in the neurodegenerative pathways of AD, PD, and ALS.
• Proposed that oxidative pathways, leading to protein and lipid destruction, are primary drivers of neurodegeneration.
• Suggests that apoptosis is a secondary response to oxidative damage.
• Heme peroxidases, including potentially cytochrome c, are implicated as catalysts for these oxidative reactions.
• Amyloid-beta peptide may function as a peroxidase in AD.
• Compounds inhibiting peroxidase activity, particularly of cytochrome c, show promise in attenuating neurodegeneration.
• Some inhibitors act as suicide substrates, suitable for targeted therapies.
• Immobilized peroxidase activity in protein aggregates could drive chronic neurodegeneration.

Conclusions:

• Oxidative reactions, potentially catalyzed by heme peroxidases, are central to neurodegeneration in AD, PD, and ALS.
• Targeting peroxidase activity, especially of cytochrome c, presents a promising therapeutic avenue.
• Inhibitors of peroxidase activity could offer effective strategies for arresting neurodegenerative disease progression.